xCT, the functional subunit of the cystine/glutamate transporter xc-system, plays a critical role in the maintenance of intracellular glutathione and redox balance. Disruption of xCT significantly inhibits the growth of a variety of carcinomas, including lymphoma, glioma, prostate and breast cancer. However, the role of xCT in tumor metastasis remains largely unknown. In this study, both xCT þ / þ and xCT À/À melanocytes were used to evaluate the role of xCT in adhesion. xCT activity was suppressed by an inhibitor, sulfasalazine (SASP), or by xCT siRNA in an esophageal cancer cell line, KYSE150. We found that disruption of xCT enhanced homotypic cell-cell adhesion and attenuated cell-extracellular matrix adhesion. SASP significantly inhibited both cell invasion of KYSE150 in vitro and its experimental metastasis in nude mice. Caveolin-1 was upregulated and b-catenin was recruited to the plasma membrane when xCT was deficient, which were followed by the inhibition of b-catenin transcriptional activity. Further study revealed that the upregulation of caveolin-1 and inhibition of tumor cell invasion were mediated by reactive oxygen species-induced p38 MAPK activation. These results first establish the role of xCT in tumor metastasis and implicate a potential target for cancer therapy.
Introduction
Esophageal squamous cell carcinoma (ESCC) is one of the most common gastrointestinal cancers, ranked as the sixth leading cause of cancer-related death in the world. Most deaths from this disease are due to metastasis that is resistant to conventional therapies (Stoner and Gupta, 2001 ; Lehrbach et al., 2003) . Great efforts have been taken to decipher this metastatic process. However, the knowledge is quite limited due to its complexity (Mehlen and Puisieux, 2006; Sahai, 2007) . It is of critical importance to identify novel players involved in tumor metastasis.
xCT, or SLC7A11 (solute carrier family 7, membrane 11), is the catalytic light chain of system xc-, an Na þ -independent heterodimeric amino-acid transport system. System xc-, consisting of xCT and a regulatory heavy chain component (4F2hc), functions as the exchange system for cystine/glutamate with cystine entry into cells in exchange for the release of glutamate at 1:1 ratio. Once inside the cells, cystine is rapidly reduced to cysteine, the rate-limiting substrate for glutathione (GSH) synthesis. Therefore, system xc-plays an important role in maintaining the cellular redox balance by regulating the intracellular GSH level (Sato et al., 1999 (Sato et al., , 2000 Kim et al., 2001) .
In our earlier studies, we demonstrated the inhibition of cell proliferation in sut/sut (sut) melanocytes and fibroblasts, in which function of xCT is null due to a replacement of its C terminus (Chintala et al., 2005) . Our recent results have further shown that the death of sut cells is likely through apoptosis mediated by JNK activation (Qiao et al., 2008) . Cystine uptake in human cancer cells is largely mediated by the system xc-, whereas the transport activity of xc-shows relatively high expressions in lung, colon and central nervous system cancer cells (Huang et al., 2005) . Therefore, modulation of xCT activity is considered as an intriguing strategy for cancer therapy. The potential has been well demonstrated in a variety of human carcinomas, including lymphoma, glioma, prostate and breast cancer. Pharmacologic inhibition of system xcremarkably inhibited proliferation of these cancer cells in vitro and attenuated tumor growth in vivo (Gout et al.,
2001
; Narang et al., 2003; Chung et al., 2005; Doxsee et al., 2007) . The underlying mechanism was attributed to the inhibition of system xc-, which causes rapid depletion of GSH, and thereby an increase in reactive oxygen species (ROS) and ultimately leads to caspasedependent apoptosis (Doxsee et al., 2007) . Current studies are mostly focused on the role of xCT in cancer cell proliferation. One recent study has shown that xCT affects glioma invasion through the autocrine glutamate signaling loop in the brain (Lyons et al., 2007) . Whether xCT is involved in a general control of tumor metastasis remains unaddressed.
Interestingly, during cultivation of xCT þ / þ and xCT À/À melanocytes, great morphological difference was observed in our current study, which indicates the involvement in cell adhesion, a critical step in tumor metastasis. We further evaluated the role of xCT in tumor metastasis in an ESCC cell line, KYSE150. Sulfasalazine (SASP), a pharmacologic inhibitor of system xc-, was used to inhibit the xCT activity. Likewise, RNAi was applied to knockdown xCT expression in this cell line. We found that disruption of xCT enhances homotypic cell-cell adhesion (CCA), attenuates cell-extracellular matrix adhesion and thus inhibits cell invasion. Most importantly, SASP significantly inhibits KYSE150 experimental metastases in nude mice. In an effort to investigate the mechanism responsible for the inhibition of metastasis, we show that disruption of xCT leads to the upregulation of caveolin-1 through ROS-mediated activation of p38 MAPK. Caveolin-1, in turn, recruits b-catenin to plasma membrane, thus enhances CCA, suppresses b-catenin transcriptional activity and inhibits cell invasion.
Results

Disruption of xCT inhibits cell invasion in vitro
The role of xCT in metastasis remains largely unknown. Interestingly, significant change in cell morphology of cultured melanocytes was observed when xCT was null. In contrast to wild-type melanocytes, which are characteristic of mesenchymal cells, xCT À/À melanocytes showed epithelial cell-like phenotype, characterized by being flatter and larger, forming tight CCA, and growing on monolayer (Figure 1a ). To further identify the phenotypic change, cell contact inhibition and homotypic CCA were examined in both xCT wild-type and mutant melanocytes. Melanocytes were plated and collected at different densities for cell cycle analysis. As shown in Figures 1b and c, S phase was decreased with the increased culture density in xCT À/À melanocyte, but remained unchanged in xCT þ / þ melanocyte, indicating that disruption of xCT induces contact growth inhibition. Homotypic CCA analysis showed that CCA of xCT À/À melanocytes was consistently higher than that of wild-type counterpart at different time points (Figure 1d ), suggesting a negative regulation of homotypic cell adhesion by xCT. Enhanced homotypic cell adhesion is always coupled with reduced cell-extracellular matrix adhesion (CMA). As expected, a reduction of CMA was observed in xCT À/À melanocyte, as compared to that seen in wild-type control (Figure 1e ).
To further confirm the role of xCT in cell adhesion, a specific system xc-inhibitor, sulfasalazine (SASP), was used to inhibit xCT activity in ESCC cell KYSE150. Consistently, SASP treatment promoted homotypic CCA and attenuated CMA (Figures 2a and b) . Similarly, treatment of xCT þ / þ melanocytes with SASP or buthionine sulfoximine, the inhibitor of GSH synthesis, mimics the morphological changes as in xCT À/À melanocytes ( Supplementary Figure 1) , suggesting that the morphological alteration is induced by xCT disruption through GSH depletion.
Metastasis is a complex multi-stage process involving cancer cell detachment from neighboring cells, intravasation, transit in the blood or lymph, extravasation and growth at a secondary site (Stetler-Stevenson et al., 1993; Hanahan and Folkman, 1996) . The molecular mechanisms underlying the metastatic process are complicated and remain to be further delineated. The processes of cell-cell and cell-extracellular matrix adhesion are known as two critical steps (StetlerStevenson et al., 1993) . In this regard, a transwell assay was performed to evaluate the effect of SASP on cell invasion in vitro. KYSE150 was treated with SASP for 72 h and then plated on transwell filter for assay. As shown in Figures 2c and d , SASP inhibited cell invasion by more than 30-fold. Taken together, all these results suggest that disruption of xCT might enhance homotypic CCA, attenuate cell-CMA, and thus inhibit cell invasion.
Disruption of xCT upregulates caveolin-1
To explore the underlying mechanism by which xCT contributes to invasion, the effect of disruption of xCT on expression of adhesion-and invasion-associated proteins (b-catenin, E-cadherin and caveolin-1) was examined. Interestingly, caveolin-1, a principal component of caveolae membranes and a putative tumor suppressor gene (Rothberg et al., 1992; Wiechen et al., 2001; Fiucci et al., 2002) , was not detected in xCT þ / þ melanocytes, but was highly expressed in xCT À/À melanocytes ( Figure 3a) . Consistently, semiquantitative reverse transcription-PCR showed that quantities of caveolin-1 mRNA in xCT À/À melanocytes was also significantly higher than that in wild-type controls, suggesting that the upregulation of caveolin-1 is possibly due to its increased transcription (Figure 3b ). E-cadherin, a tumor suppressor with a role in cell-cell adhesion involved in the formation of a functional E-cadherin/b-catenin complex (Gottardi and Gumbiner, 2001) , was highly expressed in parallel with caveolin-1 in xCT À/À melanocytes. In contrast, b-catenin, another important adhesion-associated protein, was unchanged significantly at both protein and mRNA levels ( Figures  3a and b) .
To further confirm these observations, SASP, or specific siRNA targeted to xCT, was used to inhibit or knockdown xCT in KYSE150 cells. As shown in Figures 3a and b , both caveolin-1 and E-cadherin expression were elevated after SASP treatment or siRNA transfections. However, quantities of b-catenin mRNA recorded no significant changes. Three different siRNAs, targeted to different regions of xCT transcript, had been evaluated. Semiquantitative reverse transcription-PCR and real-time PCR showed that all three siRNAs effectively downregulated xCT expression, resulting in a reduction of mRNA level at 66, 40 and 50%, respectively (Figures 3c and d) , and eventually increased caveolin-1 and E-cadherin expression (Figures 3a and b) , which further confirms the role of xCT on the transcriptional regulation of caveolin-1 and E-cadherin.
Disruption of xCT promotes b-catenin translocation to plasma membrane b-Catenin has two distinct functions, namely, maintaining cell-to-cell adhesion and mediating the Wnt/ b-catenin signaling pathway, which are largely determined by its subcellular location (Peifer, 1997; Morin, 1999; Peifer and Polakis, 2000) . Considering the role of b-catenin in cell adhesion and the observation that CCA was enhanced by disruption of xCT, we applied immunofluorescent staining to detect the subcellular distribution of b-catenin. As shown in Figure 4a , both wild-type and mutant melanocytes showed mixed nuclear and cytoplasmic b-catenin localization at low density. However, with cell density increased, in contrast to the wild-type controls, in which localization of b-catenin remained unaltered, xCT-null melanocytes showed predominantly membrane localization.
To further confirm the effect of xCT disruption on b-catenin distribution, cell fractionation was performed. Melanocytes grown at high density were collected and fractionated into membrane, cytoplasm and nucleus. In xCT þ / þ melanocytes, b-catenin distributed in all three fractions, whereas in xCT À/À melanocytes, large xCT in cancer metastasis R-S Chen et al amounts of b-catenin resided in membrane and cytoplasmic fractions with undetectable b-catenin in the nucleus (Figure 4b ). In addition, the membraneanchored b-catenin protein level in xCT þ / þ melanocytes was much lower than that in xCT À/À melanocytes, while loading control actin remained the same, indicating that loss of xCT might induce b-catenin translocation from nucleus to membrane, which was consistent with the result of immunofluorescent staining. Interestingly, caveolin-1 was found to be colocalized with b-catenin in both cytoplasm and membrane of xCT-null melanocytes at high density ( Figure 4a ). Likewise, caveolin-1 showed similar distribution pattern to b-catenin, mainly cytoplasm and membrane resident and almost undetectable in the nucleus at high density ( Figure 4b ).
Reduced nucleus-resident b-catenin is always accompanied by inhibition of its transcriptional activity and downregulation of its downstream genes. As expected, cyclin D1, one target gene transcriptionally regulated by b-catenin in the nucleus (Shtutman et al., 1999) , was significantly downregulated in xCT-deficient melanocytes, as compared with that in wild-type controls ( Figure 4c ). Similar results were obtained in KYSE150 cells. Both SASP and xCT siRNA treatments lead to a decrease in cyclin D1 expression (Figure 4c ). b-Cateninmediated transcriptional activity of TCF was tested in cells transfected with TOPFLASH plasmid. We found that the transcriptional activity was decreased in KYSE150 cells treated with SASP (Figure 4d ), but apparently increased in HEK293T cells following transfection with xCT expression plasmid ( Figure 4e ). These results confirm that the majority of b-catenin is translocated from nucleus to membrane when xCT is disrupted.
The induction of caveolin-1 and inhibition of tumor cell invasion are through the p38 MAPK pathway triggered by oxidative stress Further effort was taken to elucidate the mechanism responsible for the upregulation of caveolin-1 induced by xCT disruption. It is well known that xCT plays a critical role in maintaining intracellular GSH level, whereas GSH is responsible for scavenging harmful intracellular ROS (Estrela et al., 2006) . Thus, xCT is essential for maintaining the homeostasis of intracellular ROS. Recently, p38 MAPK has been suggested to be involved in the transcriptional upregulation of caveolin-1 stimulated by oxidative stress (Volonte et al., 2002; Dasari et al., 2006) . We hypothesized that xCT disruption may lead to excessive accumulation of ROS and triggers oxidative stress, which activates p38 MAPK xCT in cancer metastasis R-S Chen et al and thus transactivates caveolin-1 expression and inhibits cancer cell invasion. To test this hypothesis, the intracellular GSH level was quantitated and the fluorescent probe dihydroethidium (DHE) was used to measure intracellular ROS. Loss of xCT function led to significant decrease in intracellular GSH in melanocytes or KYSE150 cells treated with SASP or transfected with xCT siRNA (Supplementary Figure 2) . Flow cytometric analysis showed that the ROS content in xCT À/À melanocytes was threefold higher than that in wild-type controls. SASP treatment in KYSE150 cells also led to an increase in ROS level by 36% (Figure 5a ). Consequently, activation of p38 MAPK was revealed by the upregulation of phosphorylated p38 (P-p38) in both xCT À/À melanocytes ( Figure 5b ) and KYSE150 cells treated with xCT siRNA or SASP (Figures 5c and d) . When SB202190 was used to specifically inhibit p38 MAPK, the upregulation of caveolin-1, P-p38 and E-cadherin in xCT À/À melanocyte (Figure 5b ) or SASPtreated KYSE150 cells was suppressed (Figure 5d ), indicating that the oxidative stress-mediated caveolin-1 upregulation is p38 MAPK dependent. It is noted that the inhibition of KYSE150 cell invasion was reversed by the addition of SB202190 in a dose-dependent manner in transwell assays (Po0.01) (Figure 5e ), thus further supporting that the inhibition of cancer cell invasion is mediated by the p38 MAPK pathway.
To further confirm the correlation among the intracellular GSH, ROS level and subsequent upregulation of activated p38, buthionine sulfoximine was used to treat xCT þ / þ melanocytes and KYSE150 cells. The intracellular GSH was reduced, whereas ROS was increased in melanocytes (Supplementary Figure 3) or KYSE150 cells (Supplementary Figure 4) . Subsequently, the level of activated p38 was also increased (Supplementary Figure 5 ). Taken together, these results further support our hypothesis that xCT disruption leads to excessive accumulation of ROS (due to the decrease of GSH), which activates p38 MAPK.
Disruption of xCT by SASP inhibits tumor metastasis in vivo
To determine the role of xCT in cell invasion in vivo, murine experimental metastasis was established and SASP was used to inhibit xCT activity. KYSE150 cells were tail-intravenously injected into Nu/Nu nude mice. A total of 12 mice were randomly separated into two groups. Each of the two groups was injected twice daily i.p. with 8 mg SASP or saline for the control mice. Considering that the inhibitory effect of xCT activity by SASP is on the kinetics of the adhesion (Figures 1  and 2 ), SASP was used starting at the second day after KYSE150 cells were tail-intravenously injected into mice to enforce the implantation of cancer cells. At the xCT in cancer metastasis R-S Chen et al end of 50 days post-tumor injection, the mice were killed and metastases on the lung surface were examined after fixation in Bouin's solution.
Visible metastases were found on the lung surface of five mice in the control group and one mouse in the SASP-treated group (Po0.05). Representative examples of lungs from both groups are shown in Figure 6a . Much higher numbers of metastatic foci on the lung surface were seen in the control animals as compared with that in the animals treated with SASP (Figures 6a  and b ) (Po0.01). The lungs were sectioned and the metastatic foci were further examined. The metastatic foci existed in all the mice injected with saline, but only three of six mice treated with SASP (Po0.05), demonstrating that the metastases in the control group were more frequent and more extensive. Multiple metastatic foci with varying sizes were seen in the control mice (Figure 6c ), whereas the metastatic foci in the SASP-treated mice were sparse and smaller (Figure 6d ). The metastatic foci from three sections were counted as the numbers of metastatic foci per lung (Figure 6e) , further supporting the effect of SASP on tumor metastasis. All these in vivo data further confirmed the role of xCT in tumor metastasis, and suggested that xCT might be a potential target for developing novel cancer therapies. The dynamics of b-catenin and caveolin-1 distribution in both xCT þ / þ and xCT À/À melanocytes. Both melanocytes grown at low or high density were fixed, incubated with anti-b-catenin or anti-caveolin-1 followed by fluorescein isothiocyanate-or tetramethyl-rhodamine isothiocyanate (TRITC) conjugated secondary antibody. After 4,6-diamidino-2-phenylindole staining, cells were examined under fluorescence microscopy (magnification Â 200). (b) The expression and distribution of b-catenin and caveolin-1 in both melanocytes. Both melanocytes grown at high density were fractionated into membrane, cytoplasm and nucleus. The expression of b-catenin and caveolin-1 in whole cell lysis or separated fraction was detected by immunoblotting analysis. b-Actin was used as a loading control. (c) Cyclin D1 expression in both melanocytes, KYSE150 cells treated with sulfasalazine (SASP) at 0.5 mM or transfected with xCT siRNA was revealed by immunoblotting analysis. Three siRNAs were used, namely S1, S2 and S3, respectively. b-Actin served as a loading control. (d) SASP inhibited b-catenin-mediated transcriptional activity of TCF. KYSE150 cells were treated with SASP at 0.5 mM for 48 h and then co-transfected with TOPFLASH or FOPFLASH, along with a Renilla construct pRL-TK. Luciferase activity was assayed at 48 h post-transfection. Each bar represents the mean ± s.d. for triplicate experiments (*Po0.01). (e) Overexpression of xCT in HEK293T cells lead to enhanced transcriptional activity of TCF mediated by b-catenin. HEK293T cells were co-transfected with xCT expression plasmid pcDNA3-xCT, TOPFLASH or FOPFLASH, along with a Renilla construct. Cells were harvested 48 h after transfection for luciferase activity assay. Each bar represents the mean ± s.d. for triplicate experiments (*Po0.01).
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Discussion
In this study, we demonstrated that xCT deficiency by a spontaneous mutation, or a selective inhibitor SASP promoted homotypic cell-cell adhesion and inhibited cell-CMA. We further showed that SASP significantly inhibited both KYSE150 cell invasion in vitro and its experimental metastasis in nude mice. Expression profiling and subcellular distribution analysis revealed that caveolin-1 was upregulated and b-catenin was translocated to the plasma membrane when xCT was disrupted, which was coupled with reduced b-catenindependent transcriptional activity and cyclin D1 expression. Employment of a p38 inhibitor (SB202190) revealed that the upregulation of caveolin-1 and inhibition of tumor cell invasion was mediated by ROS-induced p38 activation. Thus, we propose a mechanistic model for the inhibition of tumor metastasis by xCT disruption (Figure 7 ). Excessive accumulation of ROS induced by loss of xCT function triggers oxidative stress and activates p38. p38, in turn, transcriptionally upregulates caveolin-1, which recruits b-catenin to the plasma membrane, thus modulating cell adhesion and inhibiting tumor metastasis. This establishes the first link between xCT and b-catenin-regulated cancer metastasis. xCT plays a critical role in maintaining the homeostasis of cellular redox. Many studies have shown the higher expression of xCT mRNA in a broad range of cancer cell lines. It was reported that xCT was prominently expressed in all glioma samples acutely derived from five patients (Lyons et al., 2007) . Importantly, targeted inhibition of xCT has been demonstrated to suppress the growth of a variety of carcinomas ) p38 is involved in the upregulation of caveolin-1 in xCT À/À melanocyte versus wild-type control. Both xCT þ / þ and xCT À/À melanocytes were treated with a p38 inhibitor (SB202190) for 48 h, and then harvested and subjected to immunoblotting analysis. Antibodies to p38, phospho-p38 (P-p38), E-cadherin and caveolin-1 were used. b-Actin served as a loading control. (c) Downregulation of xCT by RNAi activated p38. KYSE150 cells were transfected with xCT siRNA, namely S1, S2 or S3, or control siRNA. At 48 h after transfection, cells were harvested for immunoblotting analysis. (d) p38 is involved in the upregulation of caveolin-1 in KYSE150 cells induced with SASP treatment. KYSE150 cells were pretreated with different doses of p38 inhibitor (SB202190) as indicated for 1 h, and then treated with SASP at 0.5 mM for 72 h. Cells were harvested and subjected to immunoblotting analysis. (e) p38 is involved in the inhibition of KYSE150 cell invasion by SASP. KYSE150 cells were pretreated with different doses of SB202190 as indicated for 1 h, and then treated with SASP at 0.5 mM for 48 h. Cells were harvested and subjected to transwell assay. Invaded cells were counted on five random fields per well and the average number of invaded cells per field was plotted. The data shown are representative of three independent experiments ( Po0.05, *Po0.01). The densities of P-p38 bands were quantitated, normalized to total p38 (b and c), and the average ratios are shown underneath the P-p38 blots.
xCT in cancer metastasis R-S Chen et al both in vitro and in vivo, strongly suggesting that xCT plays an important role in tumor growth and might be a potential target for cancer therapy. Consistently, we here demonstrated that SASP inhibited the growth of esophageal cancer cells (KYSE150) in a dose-dependent manner (Supplementary Figure 6a) . SASP also significantly inhibited colony formation of KYSE150 cells (Supplementary Figure 6b) . Likewise, we have observed that not only the number of metastatic foci but also the size was generally smaller than the control mice in the SASP-treated group (Figure 6 ), which may be a consequence of inhibition of cell proliferation.
One may argue that the changes in the proliferation rate by xCT inhibition may impact on the migration data. We observed that cell proliferation inhibition by SASP was cell density dependent. SASP was effective only when cells were seeded at low numbers. However, no apparent proliferation inhibition was observed when cells were seeded at high numbers (5 Â 10 4 /cm 2 ) after treated with 0.5 mM SASP (Supplementary Figure 7) . To minimize the effect of proliferation inhibition on our invasion assays, KYSE150 cells were seeded at 5 Â 10 4 / cm 2 and pretreated with 0.5 mM SASP for 72 h and then seeded into the chambers. After incubation for 16 h, cell invasion was compared between cells treated with 0.5 mM SASP and the untreated control (Figures 2c  and d ). Under our experimental conditions (between 3 and 4 days at 5 Â 10 4 /cm 2 ), no proliferation inhibition by SASP was observed ( Supplementary Figures 7c and d) and therefore the migration data would not be affected.
Reduction of b-catenin-mediated transcriptional activity (Figure 4d ) and downregulation of cyclin D1 (Figure 4c ) were observed after treatment with SASP, implying that suppression of the canonical Wnt signaling pathway might contribute to the inhibition of proliferation by SASP. Most recent work suggested that xCT can directly affect cell proliferation through regulation of AP-1 activity (Lastro et al., 2008) . AP-1 transcriptional activity is increased when xCT is overexpressed. Therefore, it is possible that suppression of AP-1 activity is also involved in the inhibition of proliferation by SASP.
Several studies have shown that caveolin-1 functions as an important player in Wnt-independent regulation of transcriptional activity of b-catenin (Lu et al., 2003; Lu and Hunter, 2004) . Caveolin-1 recruits b-catenin to caveolae membranes for its link with E-cadherin and thus promotes cell adhesion and effectively inhibits b-catenin TCF/LEF-1 signaling (Galbiati et al., 2000; Torres et al., 2007) . In addition, caveolin-1 was reported to colocalize with a variety of lipid-modified signaling molecules, including G proteins, Src-like kinases, HaRas and eNOS on caveolae membranes, and function as a negative regulator of these proteins (Li et al., 1996; Couet et al., 1997; Okamoto et al., 1998) . In our study, caveolin-1 was upregulated when the function of xCT was disrupted (Figure 3a) . In addition, colocalization of caveolin-1 and b-catenin was observed (Figure 4a) . Therefore, overexpression of caveolin-1 might stabilize the E-cadherin/b-catenin complex on membranes by suppressing the phosphorylation of b-catenin, which negatively regulate the interaction between E-cadherin and b-catenin (Piedra et al., 2003; Lee et al., 2007; Tominaga et al., 2008) .
On the other side, caveolin-1 directs the distribution of E-cadherin and increases E-cadherin expression by downregulation of transcriptional repressor snail (Volonte et al., 1999; Lu et al., 2003) , and E-cadherin is required for caveolin-1-mediated reduction of b-catenin-TCF/LEF-dependent transcription (Torres et al., 2007) . E-cadherin is also known to negatively regulate b-catenin-mediated cell adhesion and transcription by altering its subcellular distribution. In our study, Ecadherin upregulation was observed when xCT was disrupted (Figure 3a) . In addition, parallel dynamics of caveolin-1 and E-cadherin was detected in xCT À/À melanocytes or in KYSE150 cells treated with SASP (Figures 5b and d) . These results indicate a possible synergistic effect of caveolin-1 and E-cadherin on the b-catenin-regulated adhesion and invasion. Thus, caveolin-1-dependent regulation of b-catenin regulates multiple processes, including cell adhesion, proliferation, invasion and metastasis, which might be the underlying mechanism for the enhanced cell-cell adhesion and reduced tumor metastases resulting from xCT disruption. Nevertheless, we have not excluded that caveolin-1-mediated, b-catenin-independent pathways may contribute to the inhibition of tumor metastasis induced by xCT disruption.
Our finding on the novel function of xCT in tumor metastasis was mechanistically different from a recent work showing that xCT plays a role in glioma cell invasion (Lyons et al., 2007) . The underlying mechanism is that glutamate released by system xc-directly promotes cell invasion by inducing intracellular Ca 2 þ oscillations that is essential for cell migration. Although we have not tested a variety of cancer cell lines in parallel with the ESCC for a similar mechanism in cell invasion, it is suggestive that other cancer cells with higher xCT expression would have similar effects on cell invasion when xCT is disrupted, especially the melanoma cells may behave similar to the xCT À/À melanocytes when xCT is inhibited.
Taken together, our findings suggest a dual role of xCT in controlling cancer development by regulating metastasis and cell proliferation as well, which establishes the potential of xCT as a promising target for cancer therapy. A phase I/II trial is underway for evaluation of SASP as a single anticancer agent against glioblastomas (Robe et al., 2006) . Understanding the role of xCT in tumor metastasis will facilitate the clinical application of xCT-targeted cancer therapy.
Materials and methods
Cell culture
The melanocyte line from xCT À/À mice (sut) and the mela a cell line from wild-type mice were established in Dr Dorothy Bennett's laboratory (University of London) and cultured as described (Chintala et al., 2005) . The medium for both xCT þ / þ and xCT À/À melanocytes was supplemented with b-mercaptoethanol (Sigma-Aldrich, St Louis, MO, USA). Human ESCC cell line, KYSE150, was kindly provided by Dr Shimada (Kyoto University). These cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and grown at 37 1C under 5% CO 2 . 293T cells were grown in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum.
Cell adhesion assays
Cell-cell adhesion (CCA) assay was performed as described (Ji et al., 2007) . Melanocytes were plated in 12-well plates. /cm 2 were pretreated with 0.5 mM SASP (Sigma-Aldrich) for 72 h. The concentration of glutaraldehyde was adjusted to 3%, and the time points for assay were set as 60 and 120 min, respectively.
In cell-CMA assay, 96-well plates were pre-coated with 50 ml of 20 mg/ml fibronectin (Sigma-Aldrich). Cells were plated and the unattached cells were washed at different time points. The remaining viable cells were quantitated by CCK-8 kit (Dojindo, Kumamoto, Japan). Wells coated with bovine serum albumin served as a negative control, whereas wells coated with fibronectin, seeded with cells but without wash through experiment, were taken as a positive control. The CMA index was calculated as (testÀnegative control)/(positive controlÀnegative control). All adhesion experiments were done in triplicate wells and repeated at least twice.
Cell invasion assays
Cell invasion assay was performed as described earlier with some modifications. Briefly, transwell membrane (Corning, Corning, NY, USA) was coated with 20 mg/ml fibronectin. Cells at a density of 5 Â 10 4 /cm 2 were pretreated with 0.5 mM SASP for 72 h, and then seeded into the pre-coated upper chamber. The lower chamber was prefilled with medium containing 0.5 mM SASP. After 16 h of incubation, the membrane was fixed and stained using crystal violet. Cell invasion was assessed microscopically at Â 100 magnification. The number of invaded cells was counted on five random fields per well.
RNA interference
Three specific short interference RNAs (siRNA) (Genechem, Shanghai, China) targeted to different regions of xCT mRNA were synthesized and tested for efficiency in the knockdown of xCT expression. The synthesized siRNA sequences were: 5 0 -ATGCCCAGATATGCATCGT-3 0 , 5 0 -GATGTTGTTTTG CCAGTAT-3 0 , 5 0 -TTGGCTATGTGCTGACAAA-3 0 . Nonsilencing siRNA, 5 0 -TTCTCCGAACGTGTCACGTTT-3 0 , which does not show significant homology to any other sequences, was used as a negative control. GADPH siRNA, 5 0 -GTGGATATTGTTCCATCA-3 0 , served as a positive control. KYSE150 cells were transfected with siRNAs at 50 nM using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), and collected for assay at 48 h post-transfection.
Western blotting
Cells were lysed in PNP buffer (phosphate-buffered saline, 0.5% Nonidet P-40, 0.5 mmol/l sodium orthovanadate, 1 mmol/l sodium fluorine, 0.3 mmol/l disodium b-glycerophosphate and protease inhibitors (Sigma-Aldrich)), and the cellular proteins of fraction were extracted as described (Ji et al., 2007) . The protein concentration was determined by DC assay (Bio-Rad, Hercules, CA, USA). After separation on 8 or 12% SDS-PAGE, protein was transferred onto nitrocellulose membranes (Millipore, Boston, MA, USA). The blot was blocked with 5% non-fat dry milk in phosphatebuffered saline and 0.1% Tween-20, probed with primary antibody, and subsequently with horseradish peroxidaseconjugated secondary antibody (Shao et al., 2006) . The signals were detected with the enhanced chemiluminescence method (ECL kit, Applygen, Beijing, China). Polyclonal anti-E-cadherin antibody, monoclonal anti-b-catenin antibody, polyclonal anti-caveolin-1 antibody, monoclonal anti-p38 antibody and monoclonal anti-cyclin D1 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal anti-p-Tyr182-p38 antibody was obtained from Signalway Antibody Biotechnology (Pearland, TX, USA). Monoclonal anti-b-actin antibody was purchased from Sigma-Aldrich.
Murine experimental metastasis assay
Male Nu/Nu nude mice (Vital River, Beijing, China) were tailintravenously injected with 1 Â 10 6 KYSE150 cells. After injection of the tumor cells, the mice received intraperitoneal injection of saline (control) or 8 mg SASP twice a day. SASP was freshly prepared immediately before each injection. At the end of the treatment periods, the mice were killed, and the lungs were removed and fixed in Bouin's solution (75% saturated 2,4,6-trinitrophenol, 10% methanol and 5% glacial acetic acid) overnight. The total number of lung surface lesions was carefully counted on each lobe for each specimen, and the mean number per lung was used to describe experimental metastasis. Presence of tumor lesions within the lungs was confirmed by hematoxylin and eosin staining. The tumor lesions from three sections were counted as the number of metastatic foci per lung, and the mean number per lung was used to describe experimental metastasis. All procedures were approved by the Institutional Animal Care and Use Committee of Institute of Genetics & Developmental Biology (IGDB) (mouse protocol KYD2005-006).
Statistics
Quantitative data in paired groups was analysed using Student's t-test. Qualitative data was compared using w 2 test. More information about the Materials and methods is provided in the Supplementary information.
